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Fibroblast replication is regulated by exogenous signals provided by growth factors,
mediators that interact with the target cell surface and signal the cell to proliferate. A useful
model of growth regulation, the "dual control model," suggests that growth factors can be
grouped either as competence factors or as progression factors, and that optimal replication
of fibroblasts requires the presence of both types of growth factors . Although most growth
factors are soluble mediators, recent studies have demonstrated that, for some cell types, the
extracellular matrix can replace the requirement for a competence factor. Since fibronectin is
an important constituent of the extracellular matrix that interacts with specific domains on the
fibroblast surface, we examined the ability of fibronectin to act as a competence factor to
promote the growth of human diploid fibroblasts. To accomplish this, fibronectins purified
from two sources, human plasma and human alveolar macrophages, were tested for their
ability to (a) stimulate fibroblast replication in serum-free medium containing characterized
progression factors (insulin or alveolar macrophage-derived growth factor); (b) provide a
growth-promoting signal early in G, . Fibronectin stimulated fibroblast replication in a close-
dependent manner in the presence of a fixed dose of a progression factor. Conversely,
fibronectin conferred on previously unresponsive fibroblasts the ability to replicate in a close-
dependent manner when cultured with increasing amounts of a progression factor. Moreover,
fibronectin signaled growth-arrested fibroblasts to traverse G, ^-4 h closer to S phase. No
differences were observed in the ability of plasma or macrophage fibronectins to provide a
competence signal for fibroblast replication. Since fibronectin is a major component of the
extracellular matrix, these observations suggest that it may provide at least one of the signals
by which the matrix conveys the "competence" that permits fibroblasts to replicate in the
presence of an appropriate progression signal.
Fibroblast replication requires exogenous growth factors, me-
diators acting with temporal specificity in the G, phase of the
cell cycle to promote DNA synthesis and cell replication (1-
5). Analysis of this temporal specificity has led to the hypoth-
esis that there are two major categories of growth factors,
competence factors, and progression factors (5, 6). Compe-
tence factors, such as fibroblast growth factor or platelet-
derived growth factor, act early in G,, rendering the cell
responsive, for a variable number of hours, to progression
factors (7). Progression factors, such as insulin, insulin-like
growth factors, and alveolar macrophage-derived growth fac-
tor, act laterin G,, signaling the cell to continue through the
cell cycle and replicate (7, 8). Both categories ofgrowth factors
are thought to provide their signals to the target cell by
interaction with specific cell surface receptors. Moreover, as
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a general principle, cells require a signal from both compe-
tence factors and progression factors to manifest an optimal
replication rate.
Normal fibroblast replication requires, in addition to solu-
ble factors, that the cellsattach to an extracellular matrix (9).
Interestingly, studies by Gospodarowicz et al. (10-12) have
suggeted that, in addition to providing attachment sites for
cells, the extracellular matrix can, at least for some cells, act
to replace the requirement for growth factors such as fibroblast
growth factor or platelet-derived growth factor. Since both
fibroblastgrowth factor and platelet-derived growth factor are
competence factors, these observations suggest that the overall
requirements for fibroblast growth may be met by a progres-
sion factor together with the extracellular matrix serving both
as a competence factor and as a site for attachment.
1925In this context, we have hypothesized that fibronectin, a
glycoprotein component of the extracellular matrix with spe-
cific domains that bind to the fibroblastsurface and to specific
regions of various components of the extracellular matrix
(13-15), can act as a competence factor. This report demon-
strates that fibronectin is a competence factor by two criteria:
(a) the ability of fibronectin to promote fibroblast replication
in a serum-free complementation test with knownprogression
factors; and (b) the action of fibronectin early in the temporal
sequence of G, .
MATERIALS AND METHODS
Preparation of Growth Factors
Plasma Fibronectin. Fibronectin was purified from human plasma by
gelatin sepharose affinity chromatography as described by Engvall and Ruos-
lathti (16), followed by gel filtration. Briefly, 100 ml of peripheral blood were
collected by venipuncture and anticoagulatedwith EDTA. Cells were separated
from plasma by centrifugation, and the plasma was applied to a gelatin-
sepharose column. Fibronectin was eluted from the column with 6 M urea
followed by further purification of a 5-ml aliquot of the peak concentration
(-2 mg/ml) on a Sephadex G-150 column. The fibronectin content of each
fraction was quantified by an enzyme-linked immunosorbent assay as previ-
ously described (17). To reducethe probabilitythat the fibronectin was contam-
inated by trace amounts of other growth factors found in plasma, some
fibronectin preparationswere purifiedby gelatin-sepharosefollowedby heparin-
agarose chromatography. The gelatin-sepharose column was eluted with 4 M
urea, and the eluate was applied directly to a heparin-agarose column followed
by elution with 0.5 M NaCl in 60 mM Tris-HCI, pH 7.4, 5 mM EDTA, as
described by Hayashi and Yamada (18).
All fibronectin samples were adjusted to a fibronectin concentration of - 1
mg/ml with 8 M urea, and stored in aliquots in liquid nitrogen vapor. As
needed, an aliquot offibronectin wasthawed, dialyzed 1:500 againstDulbecco's
modified Eagle medium (DME'; Biofluids, Rockville, MD.) for two changes at
22°C. For each sample, fibronectin was quantified by an enzyme-linked im-
munosorbent assay following dialysis.
Alveolar Macrophage Fibronectin: To purify alveolar macrophage fibro-
nectin, --50 x 106 alveolar macrophages, obtained by bronchoalveolarlavage
of patients with fibrotic lung disorders, were cultured for 24 h at 37°C in an
atmosphere of 95% air-5% CO2 in RPMI 1640 medium (Biofluids) supple-
mented with penicillin (100 U/ml) and streptomycin (100 gg/ml) (19). Resul-
tant supernatants were dialyzed against 50 mM NaCl, 20 mM Tris HCI, pH
7.4, 2 M urea, at 22°, and then chromatographedon DEAE cellulose (Whatman
Laboratory Products, Inc., Clifton, NJ) in the same buffer with aNaCl gradient
from 50 to 300 mM. To identify the fractions containingfibronectin, an aliquot
of each fraction was dialyzed (1:500) against 150 mM NaCl, 20 mM Tris HCI,
pH 7.4, and fibronectin content was determined by an enzyme-linked immu-
nosorbent assay. Fibronectin-containing fractionswere stored in liquid nitrogen
vapor. Prior to use in growth experiments, the DEAE-purified macrophage
fibronectin wasdialyzed 1 :500 against DME andassayed for fibronectin content
by an enzyme-linked immunosorbent assay.
Alveolar Macrophage-derived Growth Factor (AMDGF). AMDGF waspu-
rified from the supernatants of alveolar macrophages obtained by bronchoal-
veolar lavage of normal individuals as previously described (8). The macro-
phages were activated by surface adherence and then cultured (24 h, 37°C) in
DME supplemented with pencillin/streptomycin. The AMDGF was partially
purified from the macrophage supernatants by ion exchange chromatography
followedby gel filtration. Briefly, 600 ml of macrophage supernatants, contain-
ing 2.1 mg ofmacrophagesecretory protein (determined by a colorimetric assay
[Bio-Rad Laboratories, Richmond CA) using BSA [Sigma Chemical Co., St.
Louis, MOI as a standard), was chromatographed on DEAE cellulose and
eluted at 4°C with a NaCI gradient (150-300 mM) buffered with 20 mM Tris-
HCI, pH 7.0. The peak of bioactivity (at -270 mM) was detected by its ability
to promote the replication of human lung frbroblasts (8). This peak was
lyophilized, resuspended in PBS, then chromatographed on Sephadex G-50 in
PBS, pH 7.4, at 4°C. The peak ofactivity eluted at 18,000 daltons, and was
stored in liquid nitrogen vapor at a concentration of 1 .2 Ag/ml. Serial dilutions
'Abbreviations used in this paper: AMDGF, alveolar macrophage-
derived growth factor; DME, Dulbecco's modified Eagle medium;
FGF, fibroblast growth factor; PDGF, platelet-derived growth factor.
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ofthe pooled peak demonstratethe half-maximal growth response at a dilution
of 10-` with the maximum response at a dilution of 10-'. This represented an
approximately 300- to 400-fold purification.
Other Growth Factors: Pituitary fibroblast growth factor (FGF) was ob-
tained from Collaborative Research Inc. (Waltham, MA) and insulin from
Sigma Chemical Co. Platelet-derived growth factor (PDGF) was partially puri-
fied as described by Vogel et al. (20).
Evaluation of Plasma Fibronectin as a
Growth Factor
All experiments were performed on HFL-1 fibroblasts (American Type
Culture Collection CCL 153), previously frozen in liquid nitrogen vapor at the
tenth to twelfth population doubling. Cells were cultivated on 100-mm tissue
culture dishes (Falcon Labware, Cockeysville, MD) in DMEsupplementedwith
10% calf serum (Colorado Serum, Denver, CO) as previously described (21),
and used for growth studies between the fifteenth and twentieth population
doubling.
To evaluate the effect of plasma fibronectin on fibroblast replication in a
defined medium, the complementation test of Stiles et al. (7) was adapted for
serum-free conditions. To accomplish this, fibroblasts were cultured on 35-mm
dishes (Falcon Labware, 5 x 10' cells/dish) in DME plus 0.4% serum for 3 d.
Cells were then rinsed three times with serum-free DME followed by cultivation
for 1 d in "complementation test medium" (DME + 5,ug/ml transferrin(Sigma
Chemical Co. plus 0.1% BSA [Sigma catalogue 78881). Under these conditions,
fibroblasts did not replicate without subsequentaddition ofgrowth factors. For
convenience, fibroblasts cultured for 3 d in serum-free DME + 0.4% serum
followed by culture for 1 d in "complementation test medium" will be referred
to as nonreplicating fibroblasts.
The basic principle of the complementation test is that nonreplicating
fibroblasts require both a competence factor and a progression factor for an
optimal replication rate. Thus, to evaluate the role of plasma fibronectin as a
growth factor, fibronectin was added to cultures of nonreplicating fibroblasts
in combination with either a characterized competence factor (FGF) or a
characterized progression factor (insulin or AMDGF), and fibroblast growth
was assessed. To accomplish this, complementation test medium containing
each growth factor individually or plasma fibronectin in combination with
either FGF, insulin, or AMDGF (at the concentrations indicated in the text)
was placed on nonreplicating fibroblasts, and the cultures were continued at
37°C. Cell counts were determined daily for 4 d with an electronic particle
counter (Coulter Electronics, Hialeah, FL). Cell counts in complementation
test medium alone served as negative controls. As a positive control, in each
experiment FGF was added to nonreplicating fibroblasts with either insulin or
AMDGF to verify a synergistic increase in cell number.
Since Clemmons (22) has demonstrated that confluent fetal frbroblasts can
release their own competence factor(s), the nonreplicating HFL-I cells at low
density used for the bioassay were evaluated for production of competence
factor(s) that might obscure the effect ofexogenously added growth factors. To
accomplish this, frbroblasts were seeded at low density in DMEM plus 0.4%
serum for 3 d and rinsed as described above, then culturedin complementation
test medium for 1, 2, 3, or 4 d, and the "conditioned medium" was collected
each day. Culture of nonreplicating frbroblasts (37°C, 3-5 d) with conditioned
medium (undiluted, 1 :2, 1:4, 1 :8) alone, or supplemented with insulin (10,ug/
ml) or AMDGF (10 ng/ml), caused no increase in cell number above control.
Thus, under the conditions used, exogenously added factors were necessary to
provide competence.
One potential problem with attributing growth-promoting properties to
fibronectin was the possibility that the preparation was contaminated with
small amounts of PDGF. Since PDGF is heat stable (23), a fibronectin prepa-
ration (I gg/ml) with or without supplemental PDGF (100 ng/ml), was boiled
(100°C, 10) min) and then evaluated in a complementation test as described
above.
To determine the effectofplasmafibronectinon the replication offibroblasts
that had been growth arrested by density inhibition rather than serum depri-
vation, confluent monolayers of frbroblasts were cultured with growth factors
and the effect on DNA synthesis was assessed. To accomplish this, frbroblasts
were seeded (5 x 10'/well in 0.25 ml DME plus 10% calf serum) onto 8-well
glass slides (Lab-Tek, Miles Laboratories, Naperville IL) and cultured in DME
plus 10% calfserum with the medium changed every other day until the cells
were confluent and no mitotic cells were observed by phase contrast micros-
copy. The confluent cells were cultured one additional day without a medium
change, rinsed three times with serum-free DME, and then cultured (30 h,
37°C) in complementation test medium containing 0.1 uCi/ml ['H)thymidine
(2 Ci/mMol, Amersham Corp., Arlington Heights, IL) plus each growth factor
individually, or both a competence factor (PDGF, FGF, or fibronectin at theconcentrationsindicated in the text) anda progression factor (AMDGF, 10 ng/
ml or insulin, 10 kg/ml). After this interval, cells were fixed in methanol:acetic
acid(3:1) and processed forautoradiography was previously described (8). DNA
synthesis in complementation medium alone served as a control. Each condi-
tion was performed in quadruplicate with >200 nuclei counted per well.
Evaluation of Macrophage Fibronectin as a
Growth Factor
Because of the difficulty of preparing sufficient amounts of macrophage
fibronectin to perform the cell counting assay, the ability of macrophage
fibronectin to act as a growth factor for fibroblasts was studied in a microassay
using DNA synthesis rather than cell number as an index of fibroblast replica-
tion. The complementation test was performed in a way analogous to that
described above except that the nonreplicating fibroblasts were cultured in
microtiter wells (10` fibroblasts/well, 96-well plates; Falcon Labware) in 0.2 ml
of complementation test medium with or without exogenous growth factors.
After a 14-h incubation at 37°C, each well was pulsed with ['H]thymidine (0.1
t,Ci/ml; 2 Ci/mMol, Amersham Corp.). After an additional 24-h incubation,
acid-precipitable ['H]thymidine incorporation was determined by scintillation
counting. ['H]Thymidine incorporation in the absence ofadded growth factors
(I 100.h 300 dpm/10' fibroblasts) wassubtractedfrom the values inthepresence
of growth factors to correct for the ['H]thymidine incorporation unrelated to
growth factor addition.
Ability of Fibronectin to Signal Fibroblasts to
Respond to Progression Factors
To evaluate the ability of fibronectin to signal fibroblasts to replicate in
response to signals from progression factors, plasma fibronectin was added to
fibroblasts suspended in complementation test medium at the time ofseeding
and then removed prior to addition of progression factors. To accomplish this,
35-mm tissue culture dishes were coated with collagen (preparedfrom lathyritic
rat skins, the gift of H. K. Kleinman, National Institute of Dental Research) as
previously described, and sterilized by exposure to ultraviolet irradiation.
Fibroblasts were prepared by incubation with trypsin (Gibco Laboratories,
Grand Island, NY 0.25%; 1 min, 22°C) to detach them from culture dishes,
washed once in DME plus soybean trypsin inhibitor to inactivate the trypsin,
washed three times in complementation test medium, and resuspended in that
same medium in the presence or absence of plasma fibronectin (1 .0 ag/ml).
Fibroblasts with or without added fibronectin were then seeded at a density of
5 x 10' cells/collagen-coated dish. After incubation overnight (14 h, 37C), the
fibroblasts were rinsed three times with DME to remove unbound fibronectin.
Cell counts were then determined to confirm equal plating efficiency. The
fibroblasts were then cultured for three d with either FGF, insulin, or AMDGF
at the concentrations indicated. At the end of the 3-d culture, the number of
cells was counted to determine the growth response.
Cell Cycle Kinetics
Previous studies have indicated that competence factors act early in the G,
phase of the cell cycle of nonreplicating BALB/C 3T3 cells (5). To determine
where, in the temporal sequence of GI, fibronectin provided its growth-pro-
moting signal to lung fibroblasts, the kinetics offibroblast DNA synthesis after
pretreatment with fibronectin was determined. Nonreplicating fibroblasts (10"
cells/well, Falcon 96-well microtiter dishes, 0.2 ml of complementation test
medium per well) were cultured for 12 h with (a) no further additions; (b)
fibronectin (1 .0 kg/ml); or (c) FGF (2 ng/ml). Following this 12-h incubation,
calf serum was added to a final concentration of 10% (i.e., to provide the
fibroblasts with a complete set of signals to replicate and thus to determine
whether the pretreatment with fibronectin shifted the time of onset of DNA
synthesis). ['H]Thymidine (0.5 1ACi/ml, 2 Ci/mMol, Amersham Corp.) was
added with the serum. At the time ofserum and ['H]thymidine addition, and
every 2 h for the subsequent 18 h, triplicate wells of fibroblasts were harvested
formeasurement ofacid-precipitable ['H]thymidineincorporation. Toestablish
the background for each time point in the assay, triplicate wells of fibroblasts
were pretreated as described above and then cultured with ['H]thymidine but
without serum. The background was then subtracted from the experimental
time points. These background values ranged from 200 .t 75 dpm/10" cells at
2 h to 900 ± 125 dpm/10` cells at 18 h.
Statistical Evaluation
Eachcondition forthecell counting experimentswas performedin duplicate,
with replicates varying by <7%. Each condition in the ['H]thymidine incor-
poration experiments was performed in triplicate. Experimental values were
compared using a two-tailed Student's t-test. The data presented are the mean
± standarddeviationofthree experiments usingfibroblastswith nearlyidentical
tissue-culture histories.
RESULTS
Fibroblast Replication in Response to
Plasma Fibronectin
Nonreplicating lung fibroblasts cultured in complementa-
tion test medium containing fibronectin and insulin were
stimulated to replicate (Fig. 1). When fibroblasts were cultured
for 3 d in DME plus 0.4% serum followed by 1 d in comple-
mentation test medium, they entered a nonreplicating state,
maintainingconstant cell numbers for an additional 5 dunless
growth factors were added. In the example shown, cultivation
of the nonreplicating fibroblasts for 5 d in complementation
test medium maintained cell number at 15 x 104 fibroblasts/
dish. Each growth factor individually caused less than a 20%
increase in cell number by the fifth day after growth factor
addition (data not shown). The addition of fibronectin (0.2
Wg/ml) and a competence factor (FGF, 1 .0 ng/ml) to the
nonreplicating fibroblasts resulted in only a slight stimulation
offibroblast replication, suggesting that fibronectin was not a
progression factor. Within 2 d there were 17 x 104 cells/dish,
and by the fifth day after growth factor addition there were
18 x 10° cells/dish, only a 20% increase in cell number. In
contrast, the addition of fibronectin (0.2 kg/ml) and progres-
sion factor (insulin, 5 Ag/ml) to nonreplicating fibroblasts
markedly stimulated fibroblast replication, suggesting that
fibronectin was a competence factor. In this regard, there were
32 x 10° cells/dish by the fifth day after growth factor addi-
tion, representing an 110% increase in cell number.
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FIGURE 1 Growth of nonreplicating fibroblasts in response to
plasma fibronectin . Fibroblasts were cultured in DME + 0.4% serum
until day 3, and then in complementation test medium until day 4.
Growth factors, in fresh complementation testmedium, were added
to these nonreplicating fibroblasts on day 4 (arrow). Shown is the
number of fibroblasts in the presence of fibronectin (0.2 yg/ml) +
insulin (5 .0 Fig/ml, O); fibronectin (0.2 pg/ml) + FGF (1 .0 ng/ml, L);
or in complementation test medium without added growth factors
(").
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192 7Dose Dependence of the Stimulation of
Fibroblast Replication by Plasma Fibronectin
Nonreplicating fibroblasts cultured in complementation
test medium manifested a dose-dependent increase in repli-
cation rate in response to fibronectin only when a progression
factor (i.e., insulin or AMDGF) was also present (Fig. 2). The
addition of fibronectin aloneto the fibroblast cultures resulted
in a modest increase in cell number. Furthermore, the addi-
tion of fibronectin and a fixed dose of a competence factor
(FGF, 2.0 ng/ml) to the fibroblast cultures resulted in little
further increase in cell number. In contrast, the addition of
fibronectin along with a fixed dose of a progression factor
(either insulin [ 10 Wg/ml] or AMDGF, [ 10 ng/ml]) resulted
in a marked increase in cell number up to - 170% above
control with a fibronectin concentration of 2.0 ug/ml. This
pattern of growth-promoting activity indicated that fibronec-
tin acted as a competence factor.
In view of these findings, it was important to demonstrate
that the dose-dependent competence signal provided by fibro-
nectin was due to the fibronectin itselfand not a contaminant
of the fibronectin preparation. To exclude the possibility that
part of the observed growth response was due to a contami-
nant of the fibronectin preparation, fibronectin was purified
by two methods: gelatin-sepharose affinity chromatography
followed by (a) gel filtration chromatography; or (b) heparin-
agarose affinity chromatography. The results with both prep-
arations were identical, suggesting that fibronectin and not a
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FIGURE 2
￿
Dose dependence of the stimulation of fibroblast repli-
cation by plasma fibronectin. Nonreplicating fibroblasts were cul-
tured with increasing amounts of fibronectin and either a progres-
sion factor or a competence factor. The resultant increase in fibro-
blast number is expressed as the percent increase in cell number
above control. Shown is the effect of fibronectin on fibroblast
replication alone (p); in the presence of the progression factor
AMDGF (10 ng/ml, E); in the presence of the progression factor
insulin (10 Ag/ml, 4p); or in the presence of the competence factor
FGF (2.0 ng/ml, A).
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In addition, to rule out the possibility that PDGF (a heat-
stable competence factor with high positive charge) might still
be contaminating the preparation, the heat stability of the
fibronectin-induced growth response was assessed. Boiling the
fibronectin resulted in complete loss of activity in the assay
described above. Supplementing the fibronectin with authen-
tic PDGF (100 ng/ml) followed by boiling resulted in that
amount of fibroblast growth observed with unboiled PDGF
(data not shown). Therefore, contamination ofour fibronectin
with PDGF did not account for the growth-promoting effects
observed.
Fibronectin not only provided a competence signal to fi-
broblasts that had been growth arrested at low density by
serum deprivation, but also provided a dose-dependent com-
petence signal to fibroblasts arrested in GI by culture to
saturating density (Table I). When confluent fibroblasts were
cultured with the characterized competence factors, PDGF or
FGF, in the presence of a progression factor (AMDGF, 10
ng/ml or insulin, 10 fig/ml) there was a dose-dependent
increase in DNA synthesis. The maximum response ranged
from 26 to 33% labeled nuclei representing -50 to 75% of
the DNA synthesis produced by the addition of 10% calf
serum. Similarly, the addition of fibronectin to the density-
arrested fibroblasts in the presence of either AMDGF or
insulin resulted in a significant though smaller increase in
fibroblast DNA synthesis (p < .01, compared with media
alone). The maximum DNA synthesis in response to fibro-
nectin was 16% labeled nuclei representing about one-third
ofthe response to 10% calfserum. In contrast, DNA synthesis
in response to each factor individually was far less, ranging
from 1 to 7% . In addition, only for PDGF and FGF individ-
ually was there a small dose-related increase in nuclear label-
ing.
Fibroblast DNA Synthesis in Response to
Macrophage Fibronectin
When nonreplicating fibroblasts were incubated in the pres-
ence of a progression factor there was an increase in the rate
TABLE I
Evaluation of the Effect of Fibronectin on Proliferation of
Density-arrested fibroblasts
Nuclei Labeled*
*Data presented as percent fibroblasts incorporating ['Hlthymidine into
nuclei during 30 h, 37°C; mean ± SD of three experiments. In the presence
of medium + 10% calf serum, the percent nuclei labeled = 45 ± 6%.
= Insulin = 10 jug/mi.





None 1±1 2±1 1±1
PDGF (ng/ml)
1 2±1 5±3 6±2
10 3±2 16±3 18±3
100 7±2 26±4 21 ±3
FGF (ng/ml)
1 3±2 12±4 15±2
10 5±3 26±3 27±5
100 6±2 31±5 33±7
Fibronectin (tug/ml)
0.1 3±3 3±2 5±3
1 .0 4±2 11±1 10±2
10 4±3 16±4 14±5of DNA synthesis in response to increased amounts of mac-
rophage fibronectin (Fig. 3). As observed with plasma fibro-
nectin, there was a macrophage fibronectin dose-dependent
increase in the fibroblast growth response in the presence of
either insulin (10 ug/ml) or AMDGF (10 ng/ml). The result
was similar to that observed when [3H]thymidine incorpora-
tion was used as the index of fibroblast replication in response
to plasma fibronectin in the presence of AMDGF or insulin
(data not shown). Comparison of the dose-response relation-
ships between macrophage fibronectin and plasma fibronectin
revealed that 50% of the maximum response occurred within
a twofold concentration range of fibronectin (80 ± 15 ng/ml
for macrophage fibronectin and 200 ± 23 ng/ml for plasma
fibronectin), indicating that there was not a major difference
in growth-promoting potency of the fibronectins from these
two different sources. Thus, both plasma and macrophage
fibronectin provided a dose-dependent competence signal for
lung fibroblasts.
Ability of Fibronectin to Signal fibroblasts to
Respond to Progression Factors
Nonreplicating fibroblasts seeded onto collagen-coated
dishes in the presence of fibronectin manifested a rapid rate
of replication after the addition of a progression factor (Fig.
4). Under the conditions used, fibroblasts seeded onto colla-
gen-coateddishes in complementation test medium had sim-
ilar plating efficiencies in the absence or presence of exoge-
nous fibronectin (1 .0 ug/ml). When fibroblasts were allowed
to adhere in the absence of fibronectin, they did not replicate
when a progression factor (insulin or AMDGF) was added.
In marked contrast, when fibroblasts were allowed to adhere
in the presence of fibronectin, there was a dose-related in-
crease in replication rate afteraddition of insulin or AMDGF.
For example, at an insulin concentration of 5 ug/ml, cell
number increased 93% above control and at 50 Ag/ml cell
number increased 125% above control. Addition of AMDGF
resulted in a similar stimulation of cell replication, with an
80% increase in cell number above control at a concentration
of 0.1 ng/ml and a 140% increase at an AMDGF concentra-
tion of 10 ng/ml. Thus, fibronectin was able to provide a
signal to fibroblasts that allowed them to replicate in response
to a progression signal.























Dose dependence of the stimulation of fibroblast DNA
synthesis by macrophage fibronectin. Nonreplicating fibroblasts
were cultured with increasing amounts of fibronectin and a pro-
gression factor. Shown is fibroblast DNA synthesis in response to
fibronectin alone ("), or in the presence of the progression factors













Ability of plasma fibronectin to signal fibroblasts to re-
spond to progression factors. Fibroblasts in suspension culture were
added to collagen-coated dishes in the presence or absence of
fibronectin (1 .0 ug/ml) and then cultured for 14 h. The plates were
rinsed three times to remove unbound fibronectin, exposed to
different concentrations of progression factors in fresh complemen-
tation test medium, and the cultures continued for an additional
three days. Resultant effects on fibroblast growth are expressed as
the percent increase in cell number above control. (A) Growth of
fibroblasts in the presence of the progression factor insulin: O, cells
exposed to fibronectin prior to insulin addition; ", no fibronectin
exposure prior to insulin addition. (ß) Growth of fibroblasts in the
presence of the progression factor alveolar macrophage-derived
growth factor (AMDGF) with (O) or without (0) prior exposure to
fibronectin. (C) Growth of fibroblasts in the presence of the com-
petence factor fibroblast growth factor (FGF) with (O) or without (0)
prior exposure to fibronectin .
fibronectin for fibroblasts was not due to a progression signal
was provided by the absence of a dose-related increase in
fibroblast replication in the presence of FGF, a known com-
petence factor (Fig. 4 C). Seeding fibroblasts in the presence
of fibronectin did not enable FGF to substantially augment
their rate of replication compared with fibroblasts seeded in
the absence offibronectin, suggesting that fibronectin was not
providing a progression signal. As a positive control, fibro-
blasts exposed to FGF (1-2.5 ng/ml) in the presence ofinsulin
(5 ug/ml) or AMDGF (10 ng/ml) demonstrated a significant
increase in fibroblast replication, an effect that was not sub-
stantially augmented by the addition of fibronectin (1 .0 ug/
ml) to the cultures (data not shown).
Evaluation of the Position of Action of Fibronectin
in the G, Phase of the Cell Cycle
Evaluation of the timing of DNA synthesis under various
conditions demonstrated that fibronectin acted as a compe-
tence factor by providing a growth-promoting signal early in
G, (Fig. 5). Underthe conditions used in these studies, without
the addition ofgrowth factors, nonreplicating lung fibroblasts
were arrested in the G, phase of the cell cycle, about 12-14 h
before the onset of S phase. Nonreplicating fibroblasts cul-
tured for 12 h with the competence factor FGF (2.0 ng/ml)
traversed about one-third of the remaining interval of G,,
arresting 8-10 h from S phase. Within the framework of this
temporal sequence of G,, fibronectin (1 .0 ug/ml) also sig-
nalled nonreplicating fibroblasts to traverse one-third of G,,
with DNA synthesis beginning 8-10 h after serum addition.
In contrast, incubation of fibroblasts for 12 h with insulin or
AMDGF prior to the addition of serum resulted in no tra-
versal of G,, i.e., there was still a 12-14-h lag for DNA
synthesis,a value similar to that for cells in complementation
test medium alone (data not shown).
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Effect of plasma fibronectin on the cell cycle kinetics of
nonreplicating fibroblasts. Nonreplicatíng fibroblasts were cultured
for 12 h with or without added growth factors followed by addition
of serum and ['Hlthymidine. Shown is ['Hlthymidine incorporation
into DNA by fibroblasts pretreated for 12 h with complementation
test medium alone (p), fibronectin (*; 1 .0 ug); or FGF (p; 2 .0 ng/
ml). Data are expressed as disintegrations per minute per 10" cells
as a function of time after addition of serum.
DISCUSSION
Fibronectin, at concentrations in the nanomolar range, can,
under the appropriate circumstances, stimulate nonreplicat-
ing human lung fibroblasts to replicate in a dose-dependent
manner. In this context, fibronectin is able to complement
the growth-promoting effects ofthe characterized progression
factors, insulin and AMDGF, by providing a competence
signal to nonreplicating fibroblasts. In providing this compe-
tence signal, fibronectin stimulates nonreplicating fibroblasts
to traverse G, ^-4 to 6 h. Thus, at least for diploid human
fibroblasts, replication can be induced in serum-free condi-
tions by a signal from the extracellular matrix component,
fibronectin, plus an additional signal provided by a progres-
sion factor.
Role of Extracellular Matrix in Growth Control
There are several lines of evidence that extracellular matrix
elements can provide growth promoting signal(s) to parenchy-
mal cells. For example, in addition to stimulating the repli-
cation of human lung fibroblasts as shown in the present
study, fibronectin augments the replication rate ofchick heart
fibroblasts (24) and human dermal fibroblasts (25). In addi-
tion, type IV collagen, a basement membrane component
intimately associated with the basal surface of epithelial cells,
promotes the replication of rat mammary epithelial cells(26).
Furthermore, bovine corneal endothelial extracellular matrix,
a highly ordered collection of several matrix elements, pro-
motes the replication ofbovine vascular endothelial cells(10).
Thus, extracellular matrix components have a role in attach-
ing and orienting parenchymal cells within an organ, and in
addition there is increasing evidence that at least some of
these components are able to provide a signal for cellular
replication.
Separation of the Role of Fibronectin in Fibroblast
Replication from its Role in Fibroblast
Attachment and Spreading
Although attachment and spreading are important pre-
requisites for fibroblast replication, and fibronectin clearly
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can mediate cell attachment and spreading (27, 28), three
lines of evidence suggest that fibronectin provides a signal
that stimulates cell replication beyond its ability to mediate
attachment and spreading, i.e., fibronectin is able to provide
a competence signal directing cell replication that is not
provided by the process of attachment and spreading.
First, under the conditions employed in this study, normal
human lung fibroblasts attached to collagen-coated dishes in
equal numbers in the presence or absence of exogenous
fibronectin. However, only fibroblasts exposed to exogenously
added fibronectin were competent to replicate in response to
progression factors. This finding suggests that attachment
alone, perhaps mediated by endogenously produced fibronec-
tin, by residual cell surface fibronectin, or by other cell surface
components (29), is not sufficient to confer responsiveness to
progression factors.
Second, consistent with our observations, Hall and Gangùly
(25) have shown that, in serum-free medium, dermal fibro-
blasts attach to tissue culture plastic but do not replicate.
However, the addition to plasma fibronectin to these attached
cells promotes both spreading and replication in a dose-
dependent manner. While this observation does not dissociate
the effects of fibronectin on spreading and replication, it
clearly provides further evidence that attachment is not suf-
ficient to promote fibroblast replication.
Third, dissociation of the effect of fibronectin on cell
spreading from the competence signal for replication is pro-
vided by our observation that fully spread lung fibroblasts
cultured for several days but not exposed to fibronectin are
unresponsive to progression factors. However, when exoge-
nous fibronectin is added, the fibroblasts respond to the
progression factors and replicate.
Mechanisms of Modulation of Cellular
Replication by the Extracellular Matrix
For the process of fibroblast replication, the dual control
model ofPledger and co-workers(6) suggests that most growth
factors can be classified as competence factors or progression
factors according to their position of action within the tem-
poral sequence of G,. Although this is still a working model
that has not been completely validated, it emphasizes the
importance of cell cycle specific signals in the control of cell
replication and thus provides a useful framework in which to
conceptualize growth signals. Competence factors, such as
FGF, act early in G, and need be present for only a few hours
to render a cell responsive to a subsequentprogression signal.
Progression factors, such as the insulin-like growth factors
and AMDGF, provide a signal later in G, that, under the
appropriate conditions, allows the cell to proceed to DNA
synthesis. In this model, both a competence signal and a
progression signal are necessary for significant cell replication
(7, 30).
While the precise mechanisms of action of either compe-
tence or progression factors are not known, in principle, they
may act directly by initiating the sequence of events leading
to replication, or indirectly by stimulating the target cell to
produce their own growth factors. With regard to progression
factors, several defined signals are capable of stimulating
human fibroblasts to produce insulin-like growth factors (31,
32), which are active at nanomolar concentrations as progres-
sion factors. Evaluation for an analogous inducible produc-
tion of competence factors by fibroblasts has not been de-
scribed. However, Clemmons (22) has demonstrated thatconfluent monolayers of human fibroblasts release compe-
tence factor(s) into the medium constitutively. This raises the
theoretical consideration that nonreplicating fibroblasts (low
density or confluent) might be signalled to divide by a growth
factor that stimulates the target cell to produce its own com-
petence factor.
Within this framework, the present study demonstrates that
fibronectin acts as a competence factor by providing a signal
early in G1, either directly or indirectly, permitting human
lung fibroblasts to proliferate in response to progression fac-
tors. Fibronectin provides this competence signal to fibro-
blasts that have been arrested in G, either by serum depriva-
tion or by growth to saturating densities. However, while
fibronectin is as potent as the well characterized competence
factors FGF and PDGF with regard to stimulating the repli-
cation of fibroblasts arrested by serum deprivation, it clearly
was not so potent as FGF or PDGF in stimulating DNA
synthesis by density-arrested fibroblasts. This difference in
potency, depending upon the method used to arrest fibroblasts
in G,, distinguishesfibronectin from other competence factors
such as FGF or PDGF.
While the applicability of the dual control model has not
been directly assessed in cells other than fibroblasts, the
concept that extracellular matrix can provide a specific signal
for cellular replication is also in accord with the work of
Gospodarowicz and Ill (10). Theseworkers demonstrated that
the requirement of bovine vascular endothelial cells for the
competence factor, FGF, was eliminated by culturing these
cells on an extracellular matrix produced by bovine corneal
endothelial cells. Interestingly, however, in contrast to the
situation with lung fibroblasts, fibronectin does not provide a
good competence signal to vascular endothelial cells when
compared with intact extracellular matrix. Together, these
observations are consistent with the concept that matrix com-
ponents provide a competence signal but that different cell
types may require different matrix components.
Although the signal provided by fibronectin in stimulating
lung fibroblast growth acts early in G1 , the growth-promoting
actions of fibronectin may occur at other times in the cell
cycle for other cells. In this context, Orly and Sato (33) have
demonstrated a marked increase in rat follicular cell replica-
tion in serum-free medium containing fibronectin, transfer-
rin, and insulin; analysis of the cell cycle specificity of the
growth-promoting signal provided by fibronectin demon-
strated that it was required for cytokinesis during M phase.
Thus, for various types of cells, fibronectin can serve an
important function in the control of replication, but these
functions may be cell specific.
Various Roles for Fibronectin in Tissue
Reconstruction and Fibrosis
The present study demonstrates that both plasma fibronec-
tin and macrophage fibronectin can provide a replication
signal to fibroblasts. Together with the known functions of
fibronectin in promoting fibroblast chemotaxis (34-36) and
attachment and spreading (27, 28), these observations suggest
a fundamental role for fibronectin in the reparative processes
following injury. For example, in wound healing where cap-
illary leak is significant and macrophages play an important
role (37), plasma fibronectin as well as macrophage fibronec-
tin may contribute in concert with other growth factors to the
increase in fibroblast numbers characteristic of this process.
Furthermore, in human fibrotic lung disease, alveolar mac-
rophages are releasing both fibronectin (34) and AMDGF
(38), factors that, together, can recruit fibroblasts (fibronec-
tin), attach fibroblasts (fibronectin), and signal replication of
fibroblasts (fibronectin and AMDGF). Consistent with this
concept, morphologic studies of the alveolar wall in these
diseases have demonstrated increased numbers of fibroblasts
(39). Thus fibronectin may by one of the stimuli that results
in expansion of the fibroblast population in various physio-
logical and pathological settings.
Receivedforpublication 4 January 1983, and in revisedform 18 July
1983.
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